The District Court for the District of Delaware found Forest Labs’ patent for sublingual or buccal compositions of asenapine and methods of using such compositions to treat mental disorders, including ...

Awakn Life Sciences (OTC:AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has entered into a global licensing agreement ...

VANCOUVER, British Columbia, June 22, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to ...

PHOENIX, AZ, Feb 07, 2012 (MARKETWIRE via COMTEX) -- Kedem Pharmaceuticals Inc. KDMP -4.17% , a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to participate ...

VANCOUVER, British Columbia, March 8, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company focused on sublingual (under the tongue) drug delivery, is ...

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of ...

A review in the Annals of Pharmacotherapy examined the literature on alternative routes of administration for antipsychotic and antidepressant medications via inhaled, intranasal, buccal, sublingual, ...

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N ...

Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study A total of 114 patients were randomly ...